fibroblasts. Inhibition of MMP-10 activity decreased collagen breakdown. In two independent cohorts of TB patients from different continents, MMP-10 was increased in both induced sputum and bronchoalveolar lavage fluid compared to controls and patients with other respiratory diseases (both p<0.05). Mtb drove 3.5-fold greater MMP-10 secretion from human macrophages than the vaccine strain BCG (p<0.001), whereas both mycobacteria upregulated TNFα secretion equally. Using overlapping short linear peptides covering the sequence of ESAT-6, a virulence factor secreted by Mtb but not BCG, we found that stimulation of human macrophages with a single specific 15 amino acid peptide sequence drove 3-fold greater MMP-10 secretion than any other peptide (p<0.001). Mtb-driven MMP-10 secretion was inhibited in a dose-dependent manner by p38 and ERK MAPK blockade (p<0.001 and p<0.01 respectively), but was not affected by inhibition of NF-ĸB.
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In summary, Mtb activates inflammatory and stromal cells to secrete MMP-10 and this is partly driven by the virulence factor ESAT-6, implicating it in TB-associated tissue destruction.
Introduction
There were 9.6 million cases and 1.5 million deaths attributed worldwide to tuberculosis (TB) in 2014, and rising drug resistance is of great concern (1). To develop new therapeutic approaches, it is critical to understand underlying mechanisms of disease. In pulmonary TB, extracellular matrix (ECM) breakdown causes cavitation and facilitates Mtb transmission (2), drug resistance (3) and also increases morbidity and mortality (4) . Matrix metalloproteinases (MMPs) are zinc dependent proteolytic enzymes, which are involved in pulmonary ECM turnover and have diverse immunological roles such as chemokine processing (5) . These enzymes may be secreted by leukocytes and stromal cells during Mtb-infection (6, 7) . Triple helical collagens (types I -III) are the primary structural fibrils of the lung, and MMP-1 and MMP-8 are the predominant secreted collagenases in TB (8, 9) .
Accumulating evidence from murine and human studies implicates the interstitial collagenase or MMP-1 as a key effector in tissue destruction and cavity formation in pulmonary TB (10, 11) . MMP-10, also known as Stromelysin-2, may promote breakdown of collagen within the ECM, by regulating MMP-1 collagenase activity at both the gene expression level and via zymogen activation (12) (13) (14) . MMP-10 has also been shown to cleave fibronectin, laminin and type IV collagen in in vitro studies (15) . A pathological role for MMP-10 in other pulmonary diseases involving ECM degradation has been reported, including lung malignancy (16) and emphysema (17) . MMP-10 activation of MMP-1 is of importance in disease models of angiogenesis (14) , and MMP-10 gene expression has been shown to be induced by some bacterial infections (18) . Besides ECM breakdown, MMPs may have additional functional roles in the immune response to infections by modulating cytokine processing, defensin activation (5), or leukocyte influx (19) . Recently, a novel role for MMP-10 on macrophage polarization was identified in Pseudomonas aeruginosa infection (20) . However, MMP-10 has not been systematically investigated in TB.
The region of difference 1 (RD1) is a key determinant of mycobacterial pathogenicity and is absent from all avirulent strains of M. bovis BCG and M. microti. Deletion of RD1 from Mtb results in significant strain attenuation (21) . The early secretory antigenic target-6 (ESAT-6) and the culture filtrate protein-10 (CFP-10) are encoded by RD1 genes Rv3874 and Rv3875, are secreted by Mtb and are highly immunogenic. They have pleiotropic effects on both innate and adaptive immune responses. For example, ESAT-6 induces macrophage apoptosis and interacts with TLR2 to decrease IL-12 secretion, which can favour a Th2 phenotype (22) . and ESAT-6:CFP-10 complexes may cause pneumocyte cell lysis facilitating Mtb dissemination in the lung (23) . ESAT-6 also regulates migratory gradients via MMP-9 (24), but the effect of ESAT-6 on MMP-derived tissue destruction has not been investigated.
In this study, we investigated MMP-10 secretion from human macrophages and stromal cells in TB. We measured MMP-10 concentrations in patients, studying sputum and bronchoalveolar lavage fluid (BALF) from two geographically distinct groups, and analysed the mechanisms regulating MMP-10 gene expression and secretion, identifying a novel role for ESAT-6 in driving MMP secretion. Town, TB and control patient recruitment, recording of data, sputum induction and processing was performed as described (25) . In the Nalanda University Hospital, Patna, TB and respiratory symptomatic patient recruitment and BALF collection and processing were performed as described (26) .
Materials and Methods

Clinical TB studies
Reagents
SB203580, PD98059 and SC-514 (Millipore, Beeston, UK) were used to block activity of p38 mitogen activated protein kinase (MAPK), extracellular signal related kinase (ERK) and nuclear factor-κB (NF-ĸB) respectively.
Anti-human MMP-10 (Abcam, Cambridge, UK) and HRP-conjugated anti-rabbit IgG (Cell Signaling, Boston, USA) antibodies were used for western blot. MMP10 neutralizing antibody and IgG2B isotype control antibody (R&D Systems, Abingdon, UK) were used for functional assays.
Lipoarabinomannan (LAM, Colorado State University, USA) and peptides covering the entire ESAT-6 sequence (Pepceuticals, Enderby, UK) were used to stimulate macrophages. Peptides sequences are shown in Table 1 . Peptide purity was>90% by mass spectrometry.
Cell culture
Human monocytes were matured over 5 days in RPMI with 100ng/ml M-CSF (R&D Systems), 2mM glutamine, 10μg/ml ampicillin and 10% heat inactivated FBS.
Macrophages in serum-free media were infected with Mtb H37Rv or BCG at multiplicity of infection (MOI) 1, which were cultured in Middlebrook 7H9 medium (BD Biosciences, Oxford, UK) and used at mid-log growth.
Normal human bronchial epithelial (NHBE) cells (Lonza, Slough, UK) were cultured according to suppliers' instructions. MRC-5 lung fibroblasts were cultured in MEM with 2mM glutamine, 10μg/ml ampicillin, 1% sodium pyruvate, non-essential amino acids and 10% FBS. Experiments commenced at 80% confluence.
Conditioned Medium from Mtb infected Monocytes (CoMtb)
CoMtb was prepared as previously described (27) . Briefly, monocytes were infected with Mtb H37Rv at a MOI 1, incubated for 24h and supernatants sterile filtered .
Medium from uninfected monocytes was termed CoMCont.
MMP-10, TNFα ELISA and Luminex assays
ELISA Duoset kits (R&D Systems) were used to measure MMP-10 and TNFα concentrations in cell supernatants. Lower detection limits were 31.2pg/ml and 15.6pg/ml respectively. MMP-10 Fluorokine beads (R&D Systems) were used to measure concentrations of MMP-10 in induced sputum and BALF samples on the Luminex 200 platform (Bio-Rad, Hertfordshire, UK). Lower detection limit was 3.2pg/ml. Assays were performed as per manufacturer's instructions.
Real-Time Polymerase Chain Reaction (RT-PCR)
Total RNA was extracted using the Purelink RNA Mini Kit (Life Technologies) and reverse transcribed with the Quantitec Reverse Transcription Kit (Qiagen, Manchester, UK). RT-PCR was performed on a Stratagene Mx3000Pro using MMP-10 and β-actin primers and probes (Applied Biosystems, Warrington, UK). Analysis was performed using ΔΔCt method.
Collagenase activity
MMP-1 collagenolytic activity was measured using EnzChek DQ type I collagen assay (Life Technologies) performed as per manufacturer's instructions. DQ collagen coated slides were used for confocal microscopy.
Statistical analysis
Statistical analysis was performed using GraphPad Prism. Mann-Whitney U, Student's unpaired t-test or one-way analysis of variance with Tukey's post hoc analysis were used as appropriate. p<0.05 was considered significant. Next, we investigated MMP-10 secretion from CoMtb-simulated pulmonary epithelial cells and fibroblasts to investigate the effects of monocyte-dependent intercellular networks. CoMtb-stimulation increased MMP-10 secretion by 4.5-fold (from 2525±208.5pg/ml to 11250±886.1pg/ml; p<0.0001) from epithelial cells (Fig. 1E ) and 10.5-fold from fibroblasts (from 641.7±152.9pg/ml to 6715.7±391.9pg/ml; p<0.0001; To confirm that MMP-10 was functionally active and affected MMP-1 collagenolytic activity, 15μg/ml MMP-10 neutralizing antibody was used to block MMP-10 activity.
Results
Mtb
Collagenolytic activity was analysed using DQ type I collagen, which fluoresces in areas of collagen degradation. A significant increase in collagen breakdown was observed in macrophages infected with Mtb by confocal microscopy, compared with uninfected controls. Inhibition of MMP-10 activity led to inhibition of DQ collagen degradation by Mtb infected macrophages ( Fig. 2A) . Similarly, in CoMtb-stimulated NHBE cells, addition of 15μg/ml MMP-10 neutralizing antibody significantly decreased collagen breakdown (p<0.0001; Fig. 2B ).
MMP-10 is increased at the site of infection in patients with pulmonary TB
To investigate the relevance of MMP-10 in clinical disease, we measured MMP-10 levels in the respiratory secretions of two separate patient cohorts. We studied induced sputum of patients with TB (mixed HIV serostatus) and non-TB controls from South Africa, and BALF of HIV-uninfected TB patients compared to patients with non-tuberculous respiratory disease from India. MMP-10 concentrations were increased in patients with TB compared to controls groups for both these cohorts ( Fig. 3; p<0.05 ). In the induced sputum study of South African patients, MMP-10 concentrations were 5067pg/ml (1440-19077pg/ml) in TB patients compared to 2648pg/ml (797-5914pg/ml) in controls. In BALF, MMP-10 concentrations were 6531pg/ml (637-11929pg/ml) in TB patients compared to 783pg/ml (76-5473pg/ml) in respiratory symptomatic controls. MMP-10 mRNA accumulation was also increased by 60% in induced sputum of TB patients compared with controls, normalised to β-actin ( Fig. 3B; p<0.05) . Therefore, these findings show that MMP-10 is present at the site of disease in pulmonary TB and that concentrations are higher in TB compared to other respiratory diseases.
MMP-10 Expression in Human macrophages is driven by virulent Mtb but not by lipoarabinomannan or the Vaccine Strain BCG
Next, we investigated whether MMP-10 secretion was driven specifically by virulent Mtb or was a non-specific response to infection. LAM is a mycobacterial cell wall component and principally a TLR2 agonist known to be important in inflammatory responses to Mtb (28) . Stimulation of macrophages with 10μg/ml LAM resulted in MMP-10 secretion which was 5% of that observed after stimulation with live Mtb (Fig.   4A ). In contrast, TNFα secretion from macrophages in response to LAM and direct Mtb infection were similar (Fig. 4B) . LAM stimulated MMP-1 secretion which was 30% of that driven by direct Mtb infection (data not shown).
Tissue destruction is not usually a feature of pulmonary infection with the vaccine strain M. bovis BCG (29) . MMP-10 concentrations following macrophage infection with BCG were 586.3±96.7pg/ml compared to 2047.7±347pg/ml from Mtb-infected macrophages at 72 hours (Fig. 4C, p<0.001) . Mtb infection of macrophages upregulated MMP-10 gene expression 4-fold more than BCG infection at 24 hours (Fig. 4D, p< 0.001) , demonstrating that the divergent effects of BCG and Mtb on MMP-10 secretion are transcriptionally regulated. In contrast, Mtb and BCG stimulated similar TNFα secretion from macrophages at 72 hours (Fig. 4E) . Colony counting confirmed equal infectious doses of Mtb and BCG were used in these experiments (data not shown).
MMP-10 secretion is dependent on a specific 15 amino acid peptide sequence in ESAT-6 of Mtb
Since BCG did not drive MMP-10 secretion and lacks the RD1 region in its genome (30), we investigated ESAT-6, a protein encoded by the RD1 region which is implicated in Mtb virulence (31) and modulation of the host immune response (32, 33) . Macrophages were stimulated with a series of short linear peptide sequences from ESAT-6 (Table 1) . Stimulation of macrophages with the total pool of all ESAT-6 peptides at a concentration of 10μg/ml caused a 17.6-fold increase in MMP-10 secretion (from 7.8±7.9pg/ml to 137.2±56.5pg/ml), while 1μg/ml ESAT-6 peptides increased MMP-10 by 4.7-fold (36.3±25.9pg/ml) compared with unstimulated macrophages at 72 hours (Fig. 5A, p<0 .001). Next, overlapping pools containing 3-4 peptides at a total concentration of 10μg/ml, defined by the matrix shown in Fig. 5B , were used to stimulate macrophages. Pools 1 and 8 were the only pools that caused significantly higher MMP-10 secretion at 72 hours than unstimulated macrophages, with a 5.2-fold and 3.9-fold upregulation respectively (Fig. 5C p<0.001 and p<0 .01).
The single peptide common to both these pools is ESAT-6 peptide 4, which has the sequence SAIQGNVTSIHSLLD (Table 1) . Stimulation of macrophages with 10μg/ml ESAT-6 peptide 4 alone drove a 3-fold increase in MMP-10 secretion of 66.7±11.7pg/ml compared to compared to the randomly selected ESAT-6 peptide 13 (present in non-stimulatory peptide matrix pools 3 and 7) and an 4-fold increase in MMP-10 when compared to control, unstimulated macrophages at 72 hours (Fig 5D   p<0 .001), confirming peptide 4 was the dominant regulator of MMP-10.
MMP-10 Secretion from Mtb-stimulated macrophages is MAPK-dependent but NF-κB independent
Next, we investigated the role of key signalling pathways in control of Mtb-driven MMP-10 secretion. p38 MAPK inhibition caused a significant dose-dependent decrease in Mtb-driven MMP-10 secretion from macrophages at 72 hours (Fig. 6A) .
ERK MAPK inhibition caused a less marked but significant decrease in MMP-10 secretion with 10μM PD98059 (Fig. 6B, p<0.01) . Similarly, blockade of both the p38 and ERK MAP kinases inhibited MMP-10 gene expression (Fig. 6C, p<0.01 ). No significant cell death was observed with the concentrations of inhibitors used.
NF-ĸB regulates gene expression of diverse MMPs including collagenases in TB (34, 35). MMP-10 does not have a consensus NF-ĸB binding site in its promoter although non-canonical binding was shown to the promoter of the related stromelysin MMP-3 (36). NF-ĸB inhibition by the IKK-2 inhibitor SC-514 did not alter
Mtb-driven MDM MMP-10 secretion (Fig. 6D) . As a control, we confirmed that 10μM SC-514 reduced Mtb driven MMP-1 secretion by 51% (Fig. 6E) , demonstrating that MMP-10 regulation is NF-κB independent.
Discussion
The stromelysin MMP-10 regulates activity of the collagenase MMP-1, which plays a central role in TB pathogenesis (8), but has not previously been investigated in TB.
In the present study, we showed that Mtb infection drives macrophage MMP-10 gene expression and secretion and investigated its regulation. MMP-10 secretion was also increased by CoMtb stimulation of pulmonary epithelial cells and fibroblasts, In clinical studies, increased MMP-10 concentrations were detected in the respiratory secretions of patients with pulmonary TB relative to non-TB controls, and compared to patients with non-tuberculous pulmonary diseases. These data were consistent between two populations from different continents. To understand tissue destruction in human TB, it is important to study TB patients since most animal models do not accurately mimic the cavitatory disease seen in man (38) . Our data are consistent with the observation that MMP-10 gene expression was 14-fold higher in human TB granulomas compared to normal lung tissue on microarray analysis (39) . Our finding of increased levels of the MMP-10 by Luminex bead array in induced sputum and BALF of TB patients shows that such increased gene expression translates to secreted protein which may augment pathology in clinical disease. Furthermore, the finding in the Indian cohort of patients that MMP-10 is increased in the BALF of TB patients compared to patients with other respiratory diseases indicates that there is some specificity in the increased MMP-10 concentrations in TB. MMP-10 activity has been implicated in other destructive pulmonary pathology, such as COPD (40), and was associated with disease severity and prognosis in patients with idiopathic pulmonary fibrosis (41) . Although our study implicated MMP-10 in the protease network upregulated in TB, as MMP-10 was increased in respiratory secretions of TB patients and at gene expression level, we did not precisely define the cellular source.
However, it is most likely due to an MMP-amplification network involving multiple cell types within the granuloma including macrophages, respiratory epithelial cells and fibroblasts.
Tissue destruction and cavitation are a feature of pulmonary TB, whereas administration of vaccine BCG does not cause lung pathology in immunocompetent individuals (29) . Mtb and BCG caused similar upregulation in TNFα secretion, showing that BCG causes a pro-inflammatory reaction, but did not upregulate MMP-10. This finding suggested that specific factors present in Mtb but not BCG were responsible for driving MMP-10 expression. RD1 is a region absent in the genome of all BCG strains and avirulent mycobacteria, but present in virulent M. bovis and Mtb (30) . Mice infected with a RD-augmented BCG in showed an increased bacterial growth rate and inflammatory cell infiltration with granuloma formation, confirming its role in pathogenesis, but an emerging paradigm is that RD1 has multiple effects to cause pathology (24, 31, 42) . We employed an overlapping pool of peptides spanning the entire ESAT-6 sequence to identify a single linear 15aa sequence which alone was sufficient to drive MMP-10 secretion from macrophages. Thus, ESAT-6-dependent MMP-10 secretion is an additional pathological mechanism through which this protein promotes Mtb virulence. This peptide, along with other ESAT-6 fragments, has been shown previously to induce specific IFN-γ -secreting T cells (43) . Therefore, it is possible that in macrophages this peptide may act as a pathogen associated molecular pattern (PAMP) to activate pattern recognition receptors (44, 45) .
There are multiple signalling pathways involved in the innate immune response to Mtb. TLR activation by Mtb infection drives activation of signalling molecules MyD88, p38, ERK, PI3K and NF-κB pathways (46, 47) . These pathways have been shown to regulate diverse MMPs in Mtb infection and other diseases, but their importance in controlling MMP-10 expression has not been assessed. MMP-10 secretion from Mtb infected macrophages was regulated by both p38 and ERK MAP kinase signalling.
ESAT-6, which we showed activated MMP-10 secretion, is also known to increase p38 and ERK MAPK phosphorylation in macrophages. MAP kinases often activate inflammatory mediators in a NF-kB dependent manner (37, 48) Tables   Table 1-ESAT-6 A MMP-10 secretion from macrophages stimulated with complete pool of 17 overlapping ESAT-6 peptides spanning the entire protein sequence (see Table 1 ). B
Matrix indicating peptides present in pools 1 to 9 pools 1-9 containing all peptides experiments performed in triplicate. *p<0.05, **p<0.01, ***p<0.001.
